![](/img/cover-not-exists.png)
Use of PRO measures to inform tolerability in oncology trials: Implications for clinical review, IND safety reporting and clinical site inspections
Kim, Janice, Singh, Harpreet, Ayalew, Kassa, Borror, Kristina, Campbell, Michelle, Johnson, Laura Lee, Karesh, Alyson, Khin, Ni A, Less, Joanne R, Menikoff, Jerry, Minasian, Lori, Mitchell, Sandra A.,Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-17-2555
Date:
December, 2017
File:
PDF, 449 KB
english, 2017